| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ritushree Kukreti | Q87148604 |
| Luciano Saso | Q57033588 | ||
| P2093 | author name string | Shrikant Kukreti | |
| Neha Kanojia | |||
| Samiksha Kukal | |||
| Gurpreet Kaur Grewal | |||
| P2860 | cites work | The ketogenic diet as a treatment paradigm for diverse neurological disorders | Q21129287 |
| Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 | ||
| The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies | Q24646616 | ||
| Neuroprotective and disease-modifying effects of the ketogenic diet | Q24646914 | ||
| Early identification of refractory epilepsy | Q28144133 | ||
| Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway | Q28238852 | ||
| Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy | Q71277350 | ||
| Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy | Q73192850 | ||
| Phenytoin-mediated oxidative stress in serum of female epileptics: a possible pathogenesis in the fetal hydantoin syndrome | Q73193951 | ||
| Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy | Q73828252 | ||
| Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats | Q74351516 | ||
| Oxidative stress in children receiving valproic acid | Q79344306 | ||
| Oxidative stress markers in surgically treated patients with refractory epilepsy | Q79754266 | ||
| [An experimental study on hepatotoxicity of topiramate in young rats] | Q79788592 | ||
| Anticonvulsive and antioxidant effects of curcumin on pilocarpine-induced seizures in rats | Q84774737 | ||
| Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. | Q50532083 | ||
| In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice. | Q53339731 | ||
| Over-expression of P-glycoprotein in malformations of cortical development. | Q54068017 | ||
| Levetiracetam exhibits protective properties on rat Schwann cells in vitro. | Q54343673 | ||
| A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine | Q57302598 | ||
| Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties | Q28302788 | ||
| Carbamazepine is not a substrate for P-glycoprotein | Q28363548 | ||
| Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier | Q28385084 | ||
| Activation of NADPH oxidase and extracellular superoxide production in seizure-induced hippocampal damage | Q28584136 | ||
| Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. | Q30374674 | ||
| Mitochondrial oxidative stress and epilepsy in SOD2 deficient mice: attenuation by a lipophilic metalloporphyrin | Q30524185 | ||
| Interaction of antiepileptic drugs with human P-glycoprotein in vitro | Q31155945 | ||
| Oxidative stress and antioxidants in epilepsy | Q31857961 | ||
| Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers | Q33770428 | ||
| Drug resistance in brain diseases and the role of drug efflux transporters. | Q33988704 | ||
| A population-based study of the prevalence, clinical characteristics and effect of ethnicity in epilepsy | Q33996521 | ||
| MDR1 gene expression in brain of patients with medically intractable epilepsy | Q34059935 | ||
| Breath acetone is a reliable indicator of ketosis in adults consuming ketogenic meals | Q34135032 | ||
| Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation | Q34152888 | ||
| The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial | Q34775862 | ||
| Mechanisms of antiepileptic drug resistance | Q35088259 | ||
| Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. | Q35538527 | ||
| Reactive oxygen species in oncogenic transformation | Q35594351 | ||
| Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. | Q35984026 | ||
| Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms | Q36157234 | ||
| Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases | Q36191368 | ||
| Molecular and cellular mechanisms of pharmacoresistance in epilepsy | Q36326554 | ||
| Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis | Q36384779 | ||
| Anticonvulsant mechanisms of the ketogenic diet | Q36714459 | ||
| Regulation of drug transporters during infection and inflammation. | Q36806226 | ||
| Intrinsic severity as a determinant of antiepileptic drug refractoriness | Q36934796 | ||
| Drug interactions between chemotherapeutic regimens and antiepileptics. | Q37274036 | ||
| Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. | Q37291393 | ||
| Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options | Q37299615 | ||
| Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected | Q37914233 | ||
| The transport of antiepileptic drugs by P-glycoprotein | Q37971249 | ||
| Ketogenic diet: an early option for epilepsy treatment, instead of a last choice only | Q38091598 | ||
| Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements | Q38098898 | ||
| Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? | Q38165544 | ||
| In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein | Q39520772 | ||
| A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy | Q39729971 | ||
| Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy | Q39751240 | ||
| Assessment of antiepileptic drugs as substrates for canine P-glycoprotein | Q40072092 | ||
| Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy | Q40329175 | ||
| Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis | Q40339152 | ||
| Neuroprotective effects of zonisamide target astrocyte. | Q42468607 | ||
| Nuclear factor-kappa B activity regulates brain expression of P-glycoprotein in the kainic acid-induced seizure rats | Q42624486 | ||
| A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats | Q42716882 | ||
| Acute and Chronic Effects of N-acetylcysteine on Pentylenetetrazole-induced Seizure and Neuromuscular Coordination in Mice | Q43186308 | ||
| Modulation of antioxidant defence system in brain of rainbow trout (Oncorhynchus mykiss) after chronic carbamazepine treatment. | Q43271860 | ||
| Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats | Q43274466 | ||
| Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro | Q43298284 | ||
| Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies. | Q43711273 | ||
| P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain | Q43815938 | ||
| Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. | Q44066990 | ||
| Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions | Q44136566 | ||
| Lipid peroxidation and antioxidative enzyme activities in childhood epilepsy | Q44263356 | ||
| Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse | Q44269265 | ||
| An In Vitro Study of New Antiepileptic Drugs and Astrocytes | Q44597530 | ||
| Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice | Q44773936 | ||
| Oxidative stress markers in the neocortex of drug-resistant epilepsy patients submitted to epilepsy surgery. | Q44790190 | ||
| Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats | Q44962371 | ||
| HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells | Q45066221 | ||
| Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of rats | Q45183144 | ||
| Oxidative stress in the hippocampus after pilocarpine-induced status epilepticus in Wistar rats | Q45308113 | ||
| Oxygen free radicals in rat limbic structures after kainate-induced seizures. | Q45975207 | ||
| Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs | Q46376109 | ||
| Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain | Q46536800 | ||
| Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation | Q46550033 | ||
| Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats | Q46725859 | ||
| Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling | Q46840766 | ||
| Oxidative stress induced by epileptic seizure and its attenuation by melatonin | Q46960704 | ||
| Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats | Q46965741 | ||
| Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. | Q46984881 | ||
| A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis | Q47780435 | ||
| Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections | Q48151932 | ||
| Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures | Q48318101 | ||
| Oxidative stress in patients with epilepsy is independent of antiepileptic drugs | Q48352398 | ||
| P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice. | Q48378208 | ||
| Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB. | Q48557558 | ||
| Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. | Q48669608 | ||
| Multidrug-resistance protein 1 in focal cortical dysplasia | Q48986589 | ||
| Mitochondrial superoxide production in kainate-induced hippocampal damage | Q49160593 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ATP-binding cassette transporter | Q286958 |
| membrane protein | Q423042 | ||
| epilepsy | Q41571 | ||
| drug resistance | Q12147416 | ||
| anticonvulsant agent | Q576618 | ||
| transport protein | Q2111029 | ||
| P577 | publication date | 2017-02-27 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance | |
| P478 | volume | 22 |
| Q90102772 | Anticonvulsant and Neuroprotective Effects of Paeonol in Epileptic Rats |
| Q99629126 | Cannabidiol protects keratinocyte cell membranes following exposure to UVB and hydrogen peroxide |
| Q90706330 | Characterization and Validation of an "Acute Aerobic Exercise Load" as a Tool to Assess Antioxidative and Anti-inflammatory Nutrition in Healthy Subjects Using a Statistically Integrated Approach in a Comprehensive Clinical Trial |
| Q64099486 | Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview |
| Q46247554 | Oxidative Stress in the Development of Genetic Generalised Epilepsy: An Observational Study in Southern Indian Population |
Search more.